Caloric restriction attenuates NLRP3 inflammasome activation and oxidative stress in leukocytes of patients with obesity
Obesity promotes chronic low-grade inflammation through metabolic stress and activation of the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. The effects of caloric restriction on this pathway in humans are poorly understood; therefore, we evaluated the impact of a 6-month hypocaloric dietary intervention in 45 adults with obesity by assessing the metabolic, inflammatory, oxidative stress, and inflammasome-related markers in peripheral blood mononuclear cells. Weight loss improved metabolic parameters, reduced oxidative stress, and decreased the expression of nuclear factor κB (NF-κB), NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), and pro-caspase-1, while there tended to be a reduction of active caspase-1. These changes were accompanied by lower circulating interleukin (IL)-1β (IL-1β) and IL-18 levels, suggesting systemic attenuation of inflammasome activity. Baseline adiposity and insulin resistance influenced the magnitude of the response to dietary intervention. These findings support caloric restriction as a strategy to mitigate obesity-associated immunometabolic dysfunction and identify the redox-inflammasome axis as a potential therapeutic target.
Authors
- Meylin Fernández-Reyes (ORCID: https://orcid.org/0000-0001-6311-8864)
- Jonathan Hermenejildo (ORCID: https://orcid.org/0000-0001-8954-6621)
- Silvia Veses
- Zaida Abad‐Jiménez (ORCID: https://orcid.org/0000-0001-6258-4724)
- Sandra López‐Domènech (ORCID: https://orcid.org/0000-0003-2067-9308)
- Víctor M. Víctor (ORCID: https://orcid.org/0000-0002-3027-3945)
- Clara Luna-Marco (ORCID: https://orcid.org/0000-0003-1704-7051)
- Milagros Rocha (ORCID: https://orcid.org/0000-0003-2923-6546)
- Julia Cacace (ORCID: https://orcid.org/0009-0000-6948-200X)
- Laura Perea‐Galera (ORCID: https://orcid.org/0009-0001-3719-3614)
- Carlos Morillas
- María Pelechá-Salvador (ORCID: https://orcid.org/0000-0002-2141-6422)
Institutions
- Instituto de Salud Carlos III (ES)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital Universitario Doctor Peset (ES)
- INCLIVA Health Research Institute (ES)
- Medical Research Network (US)
Publication Details
- Journal
- iScience
- Published
- 2026-10-05
- DOI
- https://doi.org/10.1016/j.isci.2026.117743
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00